Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Susser · SciRah

Researcher profile · Semantic Scholar

S. Susser

Share profile

S. Susser — researcher profile on SciRah

h-index: 24
Works: 96
Citations: 2,315

Most-cited papers

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
S. Susser, C. Welsch, Ya-Lan Wang, M. Zettler +8 more
2009Hepatology345 citations
Semantic Scholar
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
C. Sarrazin, S. Susser, A. Doehring, C. Lange +5 more
2011Journal of Hepatology239 citations
Semantic Scholar
Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
V. Bihrer, O. Waidmann, M. Friedrich-Rust, N. Forestier +13 more
2011PLoS ONE139 citations Open access
Semantic Scholar
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
J. Dietz, S. Susser, J. Vermehren, K. Peiffer +21 more
2017Gastroenterology133 citations
Semantic Scholar
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir.
S. Susser, J. Vermehren, N. Forestier, M. Welker +5 more
2011Journal of Clinical Virology133 citations
Semantic Scholar
Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
J. Dietz, Sven-Eric Schelhorn, D. Fitting, U. Mihm +11 more
2013Journal of Virology91 citations Open access
Semantic Scholar
Combined effects of different interleukin‐28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
J. Fischer, S. Böhm, M. Scholz, Tobias Müller +13 more
2012Hepatology89 citations
Semantic Scholar
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
C. Welsch, F. S. Domingues, S. Susser, I. Antes +7 more
2008Genome Biology87 citations Open access
Semantic Scholar
Soluble Serum CD81 Is Elevated in Patients with Chronic Hepatitis C and Correlates with Alanine Aminotransferase Serum Activity
M. Welker, D. Reichert, S. Susser, C. Sarrazin +5 more
2012PLoS ONE85 citations Open access
Semantic Scholar
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
J. Dietz, S. Susser, C. Berkowski, D. Perner +2 more
2015PLoS ONE72 citations Open access
Semantic Scholar
Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design
H. Zitzer, Gabrielle M. Heilek, K. Truchon, S. Susser +4 more
2012Journal of Clinical Microbiology59 citations Open access
Semantic Scholar
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa‐2b
J. Vermehren, S. Susser, C. Lange, N. Forestier +6 more
2012Journal of Viral Hepatitis48 citations
Semantic Scholar
A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
J. Vermehren, J. Lötsch, S. Susser, S. Wicker +4 more
2012PLoS ONE48 citations Open access
Semantic Scholar
Interferon lambda 4 genotypes and resistance‐associated variants in patients infected with hepatitis C virus genotypes 1 and 3
K. Peiffer, L. Sommer, S. Susser, J. Vermehren +7 more
2016Hepatology46 citations
Semantic Scholar
Virologic Escape during Danoprevir (ITMN-191/RG7227) Monotherapy Is Hepatitis C Virus Subtype Dependent and Associated with R155K Substitution
Sharlene R. Lim, X. Qin, S. Susser, J. B. Nicholas +12 more
2011Antimicrobial Agents and Chemotherapy44 citations Open access
Semantic Scholar
Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.
J. Vermehren, S. Susser, A. Berger, D. Perner +4 more
2012Journal of Clinical Virology43 citations
Semantic Scholar
Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients
K. Peiffer, L. Kuhnhenn, Bing-Fu Jiang, A. Mondorf +10 more
2018Journal of Infectious Diseases41 citations Open access
Semantic Scholar
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.
J. Vermehren, A. Aghemo, K. Falconer, S. Susser +5 more
2014Journal of Hepatology40 citations
Semantic Scholar
Serum microRNA‐122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy
Verena Köberle, O. Waidmann, B. Kronenberger, A. Andrei +6 more
2013Journal of Viral Hepatitis40 citations
Semantic Scholar
Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection
L. Kuhnhenn, Bing-Fu Jiang, A. Kubesch, J. Vermehren +10 more
2018Alimentary Pharmacology and Therapeutics39 citations Open access
Semantic Scholar
Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
S. Susser, J. Dietz, B. Schlevogt, E. Zuckerman +10 more
2017Journal of Hepatology31 citations
Semantic Scholar
Retreatment of Patients who Failed Daa-Combination Therapies: Real-World Experience from a Large Hepatitis C Resistance Database
J. Vermehren, S. Susser, J. Dietz, T. von Hahn +7 more
201630 citations
Semantic Scholar
HCV RNA Quantification with Different Assays: Implications for Protease-Inhibitor-Based Response-Guided Therapy
B. Fevery, S. Susser, O. Lenz, G. Cloherty +3 more
2014Antiviral Therapy29 citations Open access
Semantic Scholar
Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C
S. Susser, E. Herrmann, C. Lange, N. Hamdi +5 more
2014PLoS ONE25 citations Open access
Semantic Scholar
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.
A. Mangia, S. Susser, V. Piazzolla, E. Agostinacchio +11 more
2017Journal of Hepatology24 citations Open access
Semantic Scholar
Screening for IL28B gene variants identifies predictors of hepatitis C therapy success
A. Doehring, W. Hofmann, C. Schlecker, S. Zeuzem +4 more
2010Antiviral Therapy23 citations
Semantic Scholar
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low‐to‐moderate genetic barrier nucleoside analogs
J. Peveling-Oberhag, Eva Herrmann, B. Kronenberger, Harald Farnik +4 more
2013Journal of Viral Hepatitis21 citations
Semantic Scholar
12 DETECTION OF RESISTANT VARIANTS IN THE HEPATITIS C VIRUS NS3 PROTEASE GENE BY CLONAL SEQUENCING AT LONG-TERM FOLLOW-UP IN PATIENTS TREATED WITH BOCEPREVIR
S. Susser, N. Forestier, M. Welker, J. Vermehren +3 more
200919 citations Open access
Semantic Scholar
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
G. Grammatikos, C. Lange, S. Susser, S. Schwendy +14 more
2014PLoS ONE18 citations Open access
Semantic Scholar
65 CLONAL ANALYSIS OF MUTATIONS SELECTED IN THE HCV NS3 PROTEASE DOMAIN OF GENOTYPE 1 NON-RESPONDERS TREATED WITH BOCEPREVIR (SCH503034)
S. Susser, M. Welker, M. Zettler, A. Wohnsland +5 more
200818 citations
Semantic Scholar
European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients
S. Susser, J. Dietz, J. Vermehren, K. Peiffer +20 more
201616 citations
Semantic Scholar
Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
B. Maasoumy, B. Hunyady, V. Calvaruso, M. Makara +9 more
2014PLoS ONE16 citations Open access
Semantic Scholar
964 INCIDENCE OF VIROLOGIC ESCAPE OBSERVED DURING ITMN-191 (R7227) MONOTHERAPY IS GENOTYPE DEPENDENT, ASSOCIATED WITH A SPECIFIC NS3 SUBSTITUTION, AND SUPPRESSED UPON COMBINATION WITH PEGINTERFERON ALFA-2A/RIBAVIRIN
C. Sarrazin, Jin Hong, Sharlene R. Lim, X. Qin +5 more
200916 citations
Semantic Scholar
Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir
S. Susser, M. Flinders, H. Reesink, S. Zeuzem +6 more
2015Antimicrobial Agents and Chemotherapy15 citations Open access
Semantic Scholar
Impact of Ribavirin on HCV Replicon RNA Decline during Treatment with Interferon-α and the Protease Inhibitors Boceprevir or Telaprevir
W. Hofmann, T. L. Chung, C. Osbahr, S. Susser +7 more
2011Antiviral Therapy14 citations
Semantic Scholar
Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
C. Welsch, K. Haselow, J. Gouttenoire, M. Schneider +8 more
2015Journal of Hepatology13 citations
Semantic Scholar
Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection
J. Fischer, S. Böhm, Tobias Müller, H. Witt +10 more
2013PLoS ONE9 citations Open access
Semantic Scholar
Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage
R. Hostager, M. Ragonnet-Cronin, B. Murrell, C. Hedskog +5 more
2019Virus Evolution8 citations Open access
Semantic Scholar
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir.
B. Fevery, S. Susser, O. Lenz, G. Cloherty +6 more
2015Journal of Clinical Virology8 citations
Semantic Scholar
Review article: HCV ? STAT-C era of therapy
C. Lange, Chris Sarrazin, S. Zeuzem, M. Fried +496 more
20108 citations
Semantic Scholar
Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
B. Hunyady, M. Abonyi, Z. Gerlei, J. Gervain +18 more
2018Clinical and Experimental Hepatology7 citations Open access
Semantic Scholar
Prevalence and Clinical Importance of Hepatitis C Virus Genotype 2 K/1B Chimeras
S. Susser, J. Dietz, M. Barak, B. Schlevogt +8 more
20167 citations
Semantic Scholar
Combined effects of different IL 28 B gene variants on the outcome of dual combination therapy in chronic HCV type 1 infection
J. Fischer, S. Böhm, M. Scholz, Tobias Müller +13 more
20117 citations
Semantic Scholar
Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients.
K. Peiffer, J. Vermehren, L. Kuhnhenn, S. Susser +7 more
2018Journal of Infection and Chemotherapy6 citations
Semantic Scholar
Letter: retreatment of patients with chronic hepatitis C who have failed interferon‐free combination therapy with direct acting anti‐virals
K. Kozbial, S. Aberle, S. Susser, R. Al-Zoairy +13 more
2017Alimentary Pharmacology and Therapeutics6 citations Open access
Semantic Scholar
Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site‐directed mutagenesis of an NS4B aminoterminal basic leucine zipper
M. Welker, S. Susser, C. Welsch, D. Perner +5 more
2012Journal of Viral Hepatitis6 citations
Semantic Scholar
Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
J. Dietz, D. Rupp, S. Susser, J. Vermehren +12 more
2016PLoS ONE5 citations Open access
Semantic Scholar
P0900 : Consideration of viral resistance for optimization of direct antiviral therapy of chronic hepatitis C
J. Dietz, C. Berkowski, D. Perner, S. Susser +2 more
20155 citations
Semantic Scholar
59 COMPARISON OF TWO QUANTITATIVE HCV RNA ASSAYS IN SAMPLES FROM PATIENTS TREATED WITH A PROTEASE INHIBITOR-BASED THERAPY: IMPLICATIONS FOR RESPONSE GUIDED THERAPY
B. Fevery, S. Susser, O. Lenz, G. Cloherty +3 more
20125 citations
Semantic Scholar
771 DECLINE OF DETECTABLE RESISTANCE MUTATIONS WITHIN THE HCV NS3 PROTEASE QUASISPECIES DURING LONG-TERM FOLLOW-UP AFTER TREATMENT WITH TELAPREVIR
S. Susser, N. Forestier, J. Vermehren, N. Grigorian +3 more
20105 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Sarrazin×45
Invite
C. Sarrazin — researcher profile on SciRah
S. Zeuzem×33
Invite
S. Zeuzem — researcher profile on SciRah
J. Vermehren×17
Invite
J. Vermehren — researcher profile on SciRah
J. Dietz×13
Invite
J. Dietz — researcher profile on SciRah

×13

Invite

D. Perner — researcher profile on SciRah

E. Herrmann×11

Invite

E. Herrmann — researcher profile on SciRah

Invite

T. Berg — researcher profile on SciRah

Invite

M. Welker — researcher profile on SciRah

Invite

K. Peiffer — researcher profile on SciRah

Invite

C. Lange — researcher profile on SciRah

Invite

C. Welsch — researcher profile on SciRah

Invite

U. Karey — researcher profile on SciRah